Mirtazapin Hcs (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases norepinephrine release, and by antagonizing postsynaptic 5‑HT2 and 5‑HT3 receptors. This dual action enhances overall serotonergic and noradrenergic neurotransmission, leading to mood improvement.

The dose of Mirtazapin Hcs is individualized and set by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. The prescriber determines the appropriate starting dose and any subsequent adjustments.

Safety data for mirtazapine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mirtazapin Hcs belongs to the NaSSA class, which differs from SSRIs and SNRIs by its receptor profile. It often provides stronger sedative and appetite‑stimulating effects, making it useful for patients with insomnia or weight loss, whereas SSRIs tend to be more activating and have a different side‑effect spectrum.

Store Mirtazapin Hcs at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Mirtazapin Hcs is taken orally, usually once daily in the evening. The tablet should be swallowed whole with water and not crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious risks include the emergence or worsening of suicidal thoughts, especially early in treatment, rare blood disorders such as agranulocytosis, severe allergic reactions like anaphylaxis, and rare skin conditions such as Stevens‑Johnson syndrome. Prompt medical attention is required if any of these occur.

Mirtazapin Hcs should be avoided in patients with known hypersensitivity to mirtazapine, those currently taking monoamine oxidase inhibitors, or individuals with severe hepatic impairment unless a specialist advises otherwise. Contraindications are determined by the prescribing clinician.